Article Information
History
- March 20, 2017.
Article Versions
- You are currently viewing Version 1 of this article (March 20, 2017 - 19:05).
- Version 2 (June 27, 2017 - 14:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emma E. Davenport1,2,3,
- Tiffany Amariuta1,2,3,4,
- Maria Gutierrez-Arcelus1,2,3,
- Kamil Slowikowski1,2,3,4,
- Harm-Jan Westra1,2,3,
- Ying Zhang5,
- Stephen Pearson6,
- David von Schack5,
- Jean S. Beebe5,
- Nan Bing5,
- Michael S. Vincent5,
- Baohong Zhang5 and
- Soumya Raychaudhuri1,2,3,4,7
- 1Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
- 2Partners Center for Personalized Genetic Medicine, Boston, USA
- 3Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA
- 4Department of Biomedical Informatics, Harvard Medical School, Boston, USA
- 5Pfizer Inc., Cambridge, MA, USA
- 6Pfizer New Haven Clinical Research Unit, New Haven, CT, USA
- 7Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
- Correspondence to: Soumya Raychaudhuri, 77 Avenue Louis Pasteur, Harvard New Research Building, Suite 250D, Boston, MA 02446, USA. soumya{at}broadinstitute.org; 617-525-4484 (tel); 617-525-4488 (fax)